Log In Get Started

News Hub

Real-time financial, economic, and global news with market-focused context and analysis.

Coverage spans equities, macroeconomic data, commodities, currencies, technology, politics, and global events—paired with analysis that highlights why each development matters for traders and investors. From breaking headlines to hourly market snapshots and in-depth articles, the News Hub is designed to help you stay informed, oriented, and ahead of market-moving events.

  • No major market-moving news was published in the past hour.
  • No new economic data releases appeared in the past hour.
  • No significant policy or central bank announcements occurred in the past hour.
  • No notable geopolitical events or developments were reported in the past hour.
  • No significant corporate earnings or M&A headlines emerged in the past hour.
  • Next scheduled economic data and corporate reports remain the nearest potential catalysts.

Latest Articles

Espey Announces Special Cash Dividend of $0.75 Per Share Plus Regular Quarterly Dividend of $0.25 Per Share, and the promotion of Kaitlyn O’Neil to Chief Financial Officer
Sep 8, 2026
Ajmal Hussain
Press Releases

Espey Announces Special Cash Dividend of $0.75 Per Share Plus Regular Quarterly Dividend of $0.25 Per Share, and the promotion of Kaitlyn O’Neil to Chief Financial Officer

Espey Mfg. & Electronics Corp. announced a special cash dividend of $0.75 per share in addition to its regular quarterly dividend of $0.25 per share, payable September 25, 2026. Concurrently, Kaitlyn O'Neil was promoted to Chief Financial Officer, strengthening the company's financial leadership as it pursues growth and strategic objectives in mili…

ESP
Sun Communities, Inc. Declares Third Quarter 2026 Distribution
Sep 8, 2026
Jordan Park
Press Releases

Sun Communities, Inc. Declares Third Quarter 2026 Distribution

Sun Communities, Inc., a real estate investment trust specializing in manufactured housing and RV communities, announced a third quarter 2026 distribution of $1.12 per common share payable on October 15, 2026. The announcement demonstrates the company’s continued commitment to returning value to shareholders from its extensive portfolio of properti…

SUI
BBOT Announces New BBO-8520 Data; Highlights Strategic Focus on 2L+ NSCLC BBO-8520 Combination as Well as BBO-11818 and BBO-10203 Combinations in KRAS-Mutant Cancers
Sep 8, 2026
Marcus Reed
Press Releases

BBOT Announces New BBO-8520 Data; Highlights Strategic Focus on 2L+ NSCLC BBO-8520 Combination as Well as BBO-11818 and BBO-10203 Combinations in KRAS-Mutant Cancers

BridgeBio Oncology Therapeutics reported encouraging clinical data for its KRASG12C inhibitor BBO-8520, showing high response rates in both monotherapy and combination with pembrolizumab in non-small cell lung cancer (NSCLC) patients. The company is prioritizing BBO-8520 combinations in 2L+ KRASG12C inhibitor-experienced NSCLC and advancing BBO-118…

BBOT
Carlsmed, Inc. Announces Chief Operating Officer Appointment
Sep 8, 2026
Derek Hwang
Press Releases

Carlsmed, Inc. Announces Chief Operating Officer Appointment

Carlsmed, Inc., a Nasdaq-listed medical technology company specializing in AI-enabled personalized spine surgery solutions, has promoted Jeff Bertolini to Chief Operating Officer. Bertolini's history with the company includes leadership roles focused on operational excellence and advanced manufacturing technologies. The management believes his expe…

CARL
New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery versus laparoscopic and open surgery across 13 common benign conditions
Sep 8, 2026
Priya Menon
Press Releases

New meta-analysis shows statistically significant improvements in patient outcomes associated with da Vinci surgery versus laparoscopic and open surgery across 13 common benign conditions

Intuitive Surgical announced a comprehensive meta-analysis demonstrating that da Vinci robotic-assisted surgery offers statistically significant benefits compared to laparoscopic and open surgeries across 13 common benign conditions. The study analyzed data from over 14 million procedures internationally, highlighting improved perioperative outcome…

ISRG
ServiceTitan Names Rikus Pretorius Next Chief Revenue Officer
Sep 8, 2026
Marcus Reed
Press Releases

ServiceTitan Names Rikus Pretorius Next Chief Revenue Officer

ServiceTitan named Rikus Pretorius, former Senior Vice President of Worldwide Sales, as its new Chief Revenue Officer effective from the start of the fiscal fourth quarter. Pretorius succeeds Ross Biestman, who is stepping back from day-to-day operations after nearly a decade as CRO but will remain an advisor through fiscal 2027 to ensure a smooth …

TTAN
ServiceTitan Announces Fiscal Second Quarter Financial Results
Sep 8, 2026
Caleb Monroe
Press Releases

ServiceTitan Announces Fiscal Second Quarter Financial Results

ServiceTitan, a leading software platform for contractors and trades, announced its fiscal second quarter 2027 financial results highlighting 21% year-over-year revenue growth to $292.8 million and generating over $50 million in non-GAAP free cash flow. The company emphasized accelerating adoption of its AI-enhanced Agentic Operating System, with o…

TTAN
CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026
Sep 8, 2026
Jordan Park
Press Releases

CAMP4 Therapeutics to Host Virtual Analyst Day to Discuss CMP-002 for the Treatment of SYNGAP1-Related Disorder on September 28, 2026

CAMP4 Therapeutics announced a virtual Analyst Day on September 28, 2026, to present details on CMP-002, a novel antisense oligonucleotide therapeutic designed to treat SYNGAP1-related disorder, a rare genetic condition with no approved disease-modifying therapies. The company plans to initiate a Phase 1/2 clinical trial of CMP-002 in Q4 2026 and w…

CAMP
Korsana Biosciences Completes Closing of Merger with Cyclerion Therapeutics and Previously Announced Private Placement of $380 Million
Sep 8, 2026
Sofia Navarro
Press Releases

Korsana Biosciences Completes Closing of Merger with Cyclerion Therapeutics and Previously Announced Private Placement of $380 Million

Korsana Biosciences finalized its merger with Cyclerion Therapeutics and completed a $380 million private financing, positioning the company with approximately $475 million in cash to fund operations into 2029. The combined company will begin trading on Nasdaq under ticker KRSA starting September 9, 2026. Korsana’s lead program, KRSA-028, a next-ge…

KRSA
Pyxis Oncology to Host Webcast to Present Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)
Sep 8, 2026
Ajmal Hussain
Press Releases

Pyxis Oncology to Host Webcast to Present Updated Data from Phase 1 Monotherapy Study of Micvotabart Pelidotin (MICVO) in Second-Line and Beyond Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma (2L+ R/M HNSCC)

Pyxis Oncology announced a live webcast to present updated clinical data from its Phase 1 study of micvotabart pelidotin (MICVO) as monotherapy in patients with second-line and beyond recurrent/metastatic head and neck squamous cell carcinoma (R/M HNSCC). The presentation will cover efficacy, safety, dosing details, and next clinical development st…

PYXS
Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program
Sep 8, 2026
Avery Klein
Press Releases

Assembly Biosciences Exercises U.S. Profit-Share Option with Gilead for HSV Helicase-Primase Inhibitor Program

Assembly Biosciences has exercised its option to share 40% of U.S. development costs and profits in collaboration with Gilead Sciences for its investigational helicase-primase inhibitor program targeting recurrent genital herpes. The decision follows review of Gilead’s development plan and advances the GS-1179 candidate toward a Phase 2 clinical tr…

ASMB
Northern Technologies International Corporation Announces New President and CEO and Other Key Leadership Appointments
Sep 8, 2026
Hana Yamamoto
Press Releases

Northern Technologies International Corporation Announces New President and CEO and Other Key Leadership Appointments

Northern Technologies International Corporation (NTIC) has appointed Gautam Ramdas as President and CEO, succeeding G. Patrick Lynch who becomes Chairman of the Board. Brian Haglund is promoted to Chief Operating Officer. These leadership changes are part of NTIC's succession planning designed to capitalize on growth opportunities, especially in co…

NTIC
Nike Investors Reject Measure Seeking Greater Climate Disclosure
Sep 8, 2026
Leila Farooq
Stock Markets

Nike Investors Reject Measure Seeking Greater Climate Disclosure

Nike shareholders on Tuesday declined a resolution that would have required the company to disclose more granular information about its climate objectives and the strategies intended to achieve emissions reductions. The vote leaves intact management control over sustainability disclosures even as the company navigates financial pressures, political…